Global Information
회사소개 | 문의 | 비교리스트

세계의 유전자 편집 및 게놈 엔지니어링 시장 예측(-2025년) : CRISPR, TALEN, ZFN, 안티센스

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User & Region-Global Forecast to 2025

리서치사 MarketsandMarkets
발행일 2020년 06월 상품 코드 942630
페이지 정보 영문 148 Pages
가격
US $ 4,950 ₩ 5,575,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,489,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,179,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,263,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 유전자 편집 및 게놈 엔지니어링 시장 예측(-2025년) : CRISPR, TALEN, ZFN, 안티센스 Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User & Region-Global Forecast to 2025
발행일 : 2020년 06월 페이지 정보 : 영문 148 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 유전자 편집·게놈 엔지니어링 시장은 예측 기간 중 17.0%의 CAGR로 추이하며, 2020년의 51억 달러에서 2025년에는 112억 달러 규모로 성장할 것으로 예측됩니다. 정부 자금의 투입 확대, 게노믹스 프로젝트 건수의 증가, 감염증 및 암의 높은 유병률, 기술적 진보, GM 작물의 생산량 증가, 게노믹스의 응용 분야 확대 등의 요인이 이 시장의 성장을 촉진하고 있습니다. 한편, 게놈 기기의 고비용성이 시장의 성장을 방해하고 있습니다. 기술별로 보면 기술의 취급 용이성 및 멀티플렉스 기능으로 인해 CRISPR 부문이 2019년 최대의 점유율을 획득했습니다. 또한 최종사용자별로는 제약회사가 같은 해 최대의 점유율을 획득했습니다. 이 부문의 성장은 감염증 및 암의 유병률 증가로 인한 의약품 개발의 활발화에 기인하고 있습니다. 지역별로는 아시아태평양이 예측 기간 중 최대의 CAGR을 보일 것으로 예측됩니다. 이 지역 제약·바이오의약품 업계의 급성장, 게놈 프로젝트의 증가, 유전적으로 다양한 인구의 존재 등의 요인이 이 지역의 높은 성장률을 지원하고 있습니다.

세계의 유전자 편집·게놈 엔지니어링 시장을 조사했으며, 시장의 정의와 개요, 밸류체인, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 기술·용도·제품 & 서비스·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업 개요 등을 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 개요

제4장 프리미엄 인사이트

제5장 시장 개요

  • 서론
  • 시장 역학
    • 촉진요인
    • 시장 기회
    • 과제
  • 밸류체인 분석
  • COVID-19의 영향

제6장 시장 분석·예측 : 기술별

  • 서론
  • CRISPR
  • TALEN
  • ZFN
  • 안티센스
  • 기타

제7장 시장 분석·예측 : 용도별

  • 서론
  • 세포주 엔지니어링
  • 유전자 공학
    • 동물 유전자 공학
    • 식물 유전자 공학
  • 진단
  • 약물 발견·개발
  • 기타

제8장 시장 분석·예측 : 제품·서비스별

  • 서론
  • 시약·소모품
  • 소프트웨어·시스템
  • 서비스

제9장 시장 분석·예측 : 최종사용자별

  • 서론
  • 제약회사
  • 바이오테크놀러지 기업
  • 학술·정부 연구기관

제10장 시장 분석·예측 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 프랑스
    • 독일
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동·아프리카

제11장 경쟁 구도

  • 서론
  • 시장 순위 분석
  • 시장 평가 프레임워크
  • 경쟁 리더십 지도제작
  • 경쟁 시나리오

제12장 기업 개요

  • THERMO FISHER SCIENTIFIC
  • MERCK
  • HORIZON DISCOVERY
  • GENSCRIPT
  • SANGAMO THERAPEUTICS
  • LONZA
  • EDITAS MEDICINE
  • CRISPR THERAPEUTICS
  • EUROFINS SCIENTIFIC
  • PRECISION BIOSCIENCES
  • OXFORD GENETICS
  • INTELLIA THERAPEUTICS
  • SYNTHEGO
  • VIGENE BIOSCIENCES
  • EPIGENIE
  • INTEGRATED DNA TECHNOLOGIES
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • TRANSPOSAGEN BIOPHARMACEUTICALS
  • CREATIVE BIOGENE

제13장 부록

KSA 20.07.03

LIST OF TABLES

  • TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 2 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 3 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 4 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 5 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 6 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 11 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 16 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 21 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)  
  • TABLE 24 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 25 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 32 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 37 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 42 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 47 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)  
  • TABLE 49 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 50 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 51 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 52 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 53 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 54 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 58 ROW: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 59 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 63 ROW: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 64 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 68 ROW: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 70 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 71 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 72 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 73 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)  
  • TABLE 74 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 79 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 84 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 87 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 88 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 89 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 90 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 91 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 92 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 93 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 94 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 95 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 96 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 97 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)  
  • TABLE 98 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 99 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 100 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 101 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 102 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 103 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 104 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 105 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 107 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 108 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 109 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 110 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 111 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 113 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 114 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 115 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 116 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 117 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 118 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 119 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 120 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 121 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 122 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)  
  • TABLE 123 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 124 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 125 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 126 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 127 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 128 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 129 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 130 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 131 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 132 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 133 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 134 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 135 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 136 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 137 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 138 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 139 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 140 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 141 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 142 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 143 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 144 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 145 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 146 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 147 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)  
  • TABLE 148 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 149 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 150 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 151 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 152 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 153 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 154 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH WAS THE MAJOR STRATEGY ADOPTED BY MAJOR PLAYERS IN 2017

LIST OF FIGURES

  • FIGURE 1 BREAKDOWN OF PRIMARIES
  • FIGURE 2 DATA TRIANGULATION METHODOLOGY
  • FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE (USD BILLION)
  • FIGURE 4 GENOME EDITING/GENOME ENGINEERING MARKET CAGR PROJECTIONS FROM AN ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • FIGURE 5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY APPLICATION, 2019
  • FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2020-2025
  • FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
  • FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING/GENOME ENGINEERING MARKET
  • FIGURE 9 RISING R&D FUNDING AND HIGH PREVALENCE OF INFECTIOUS DISEASES ARE THE PRIMARY GROWTH DRIVERS FOR THE MARKET
  • FIGURE 10 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET
  • FIGURE 11 CELL LINE ENGINEERING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
  • FIGURE 12 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
  • FIGURE 13 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • FIGURE 14 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2020 VS. 2025
  • FIGURE 15 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
  • FIGURE 16 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
  • FIGURE 17 COMPANY RANKING IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019
  • FIGURE 18 GENOME EDITING/GENOME ENGINEERING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • FIGURE 20 MERCK: COMPANY SNAPSHOT (2019)
  • FIGURE 21 HORIZON DISCOVERY: COMPANY SNAPSHOT (2018)
  • FIGURE 22 GENSCRIPT: COMPANY SNAPSHOT (2019)
  • FIGURE 23 SANGAMO THERAPEUTICS: COMPANY OVERVIEW (2019)
  • FIGURE 24 LONZA: COMPANY SNAPSHOT (2019)
  • FIGURE 25 EDITAS MEDICINE: COMPANY SNAPSHOT (2018)
  • FIGURE 26 CRISPR THERAPEUTICS: COMPANY SNAPSHOT (2019)
  • FIGURE 27 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • FIGURE 28 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2019)

"Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market."

The global genome editing/genome engineering market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

"CRISPR commanded the largest share of the market in 2019."

Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.

"Pharmaceutical companies commanded the largest share of the genome editing/genome engineering market in 2019."

By end user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.

"The Asia Pacific region will register the highest growth in the global genome editing/genome engineering market during the forecast period."

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the genome editing/genome engineering market.

  • By Respondent Type: Supply Side (80%) and Demand Side (20%)
  • By Designation: D-level (55%), C-level (20%), and Others (25%)
  • By Region: North America (50%), Europe (20%), Asia Pacific (20%), and RoW (10%)

The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), and Sangamo Therapeutics (US).

The study includes an in-depth competitive analysis of these key players in the genome editing/genome engineering market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the genome editing/genome engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, such as products, technology, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET DATA ESTIMATION & TRIANGULATION
    • 2.2.1 DATA TRIANGULATION
  • 2.3 MARKET ESTIMATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY SOLUTION AND COUNTRY (2019)
  • 4.3 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION (USD MILLION)
  • 4.4 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2019

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising government funding and growth in the number of genomics projects
      • 5.2.1.2 Expanding application areas of genomics
      • 5.2.1.3 Introduction of CRISPR-Cas9
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Extensive use of genome editing in personalized medicine
      • 5.2.2.2 Emerging markets
    • 5.2.3 CHALLENGES
      • 5.2.3.1 High equipment costs
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET

6 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 CRISPR
    • 6.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES
  • 6.3 TALEN
    • 6.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN
  • 6.4 ZFN
    • 6.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH
  • 6.5 ANTISENSE
    • 6.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
  • 6.6 OTHER TECHNOLOGIES

7 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CELL LINE ENGINEERING
    • 7.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH
  • 7.3 GENETIC ENGINEERING
    • 7.3.1 ANIMAL GENETIC ENGINEERING
      • 7.3.1.1 Use of animal simulation models in research to increase the demand for genome editing
    • 7.3.2 PLANT GENETIC ENGINEERING
      • 7.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops
  • 7.4 DIAGNOSTIC APPLICATIONS
    • 7.4.1 GROWING APPLICATION HORIZON IN DIAGNOSTICS WILL FAVOR MARKET GROWTH
  • 7.5 DRUG DISCOVERY & DEVELOPMENT
    • 7.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH
  • 7.6 OTHER APPLICATIONS

8 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE

  • 8.1 INTRODUCTION
  • 8.2 REAGENTS & CONSUMABLES
    • 8.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE
  • 8.3 SOFTWARE & SYSTEMS
    • 8.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE
  • 8.4 SERVICES
    • 8.4.1 WIDE APPLICATION OF SERVICES TO INCREASE MARKET GROWTH

9 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL COMPANIES
    • 9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES
  • 9.3 BIOTECHNOLOGY COMPANIES
    • 9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES
  • 9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH

10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 US dominates the North American market
    • 10.2.2 CANADA
      • 10.2.2.1 Availability of research funding in Canada drives the market growth
  • 10.3 EUROPE
    • 10.3.1 UK
      • 10.3.1.1 UK is the largest market for genome engineering in Europe
    • 10.3.2 FRANCE
      • 10.3.2.1 Government funding for genomics and rising investments into research show potential for market growth
    • 10.3.3 GERMANY
      • 10.3.3.1 Strong academic base and rising awareness are key growth drivers in Germany
    • 10.3.4 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 China to hold the largest share of the market in the Asia Pacific
    • 10.4.2 JAPAN
      • 10.4.2.1 Focus on cancer research showcases favorable scenario for the market in Japan
    • 10.4.3 INDIA
      • 10.4.3.1 Growing number of startups and government support indicates growth potential
    • 10.4.4 REST OF ASIA PACIFIC
  • 10.5 ROW
    • 10.5.1 LATAM
      • 10.5.1.1 Latin America is an attractive market for genomics in the RoW
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET RANKING ANALYSIS
  • 11.3 MARKET EVALUATION FRAMEWORK
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
    • 11.4.1 VISIONARY LEADERS
    • 11.4.2 DYNAMIC DIFFERENTIATORS
    • 11.4.3 INNOVATORS
    • 11.4.4 EMERGING COMPANIES
  • 11.5 COMPETITIVE SCENARIO
    • 11.5.1 KEY PRODUCT LAUNCHES
    • 11.5.2 KEY PARTNERSHIPS & COLLABORATIONS
    • 11.5.3 KEY ACQUISITIONS

12 COMPANY PROFILES (Business overview, Products and Services offered, Recent developments, MNM view)*

  • 12.1 THERMO FISHER SCIENTIFIC
  • 12.2 MERCK
  • 12.3 HORIZON DISCOVERY
  • 12.4 GENSCRIPT
  • 12.5 SANGAMO THERAPEUTICS
  • 12.6 LONZA
  • 12.7 EDITAS MEDICINE
  • 12.8 CRISPR THERAPEUTICS
  • 12.9 EUROFINS SCIENTIFIC
  • 12.10 PRECISION BIOSCIENCES
  • 12.11 OXFORD GENETICS
  • 12.12 INTELLIA THERAPEUTICS
  • 12.13 SYNTHEGO
  • 12.14 VIGENE BIOSCIENCES
  • 12.15 EPIGENIE
  • 12.16 INTEGRATED DNA TECHNOLOGIES
  • 12.17 NEW ENGLAND BIOLABS
  • 12.18 ORIGENE TECHNOLOGIES
  • 12.19 TRANSPOSAGEN BIOPHARMACEUTICALS
  • 12.20 CREATIVE BIOGENE

*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q